AKBA trade ideas
$AKBA Therapeutics $1.25 is already programmed - Long/CallFully expect a good earnings report. Positive news from the company. Nothing but good news as far as this company is concerned. Earnings posting this week, and will not disappoint. We could see a nice jump up here.
Possible trend change on AKBAOn the weekly chart: We're hitting a major horizontal support line on the weekly chart.
On the daily chart: we have a nice doji candle.
Could be a start for an uptrend if we break over 2:57
Weekly price action tends to have more weight on the price. Could be one of the double your money moves.
I'm not a financial advisor.
Do your own research!
Khan's Live-Charting 02 - $AKBATwo downward triangles combined, for now EMA 20,50 is hard resistance - needs to push through. Beside catalysts i would be very careful with a swing trade in this one
AKBA LongWeekly Demand Zone
Entry 2.47
Stop 1.9
Target 5
Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
AKBA 4HRNASDAQ:AKBA 4HR chart is setting up a nice buy signal. It has a very large rounded base followed by a trendline break. Additionally, the 50 EMA is about to cross above the 200 EMA.
Bullish tradeThis was alerted on the Transparent Traders Black Box as a bullish swing trade. Our indicators on TradingView also are showing bullish as well. I am looking for entry at 3.36, stop loss at 2.83, target between 4.10 to 5.07.
$AKBA is a bullish sharkshark harmonic pattern targets:
AB=0.61 XA
BC=1.6 AB
tp1=0.88 XA=$25
tp2=1.13 XA=$38
tp3=1.6 BC=$82
tp4=2.24 BC=$340
other targets:
tp5=0.78 BC=$12
tp6=0.88 BC=$15
tp7=0.78 XA=$$21
tp8=1.6 XA=1.6 BC=$82
AKBA - Long Setup Looking for a break above 5.11. Stop signal 4.31. First target 6.43 , Second target momentum.
$AKBA - Fib run is testing 0.236 run of 100% likely.$AKBA is a heavily shorted bio-technology company that recently won DOD funding for one of their phase three candidates. I think the bullish trend is just getting started and a real shove will add 100% or more to the price of the stock.
Next leg up next weekI like this one for next week. This ascending channel has an established uptrend and presents an attractive risk/reward at 3.05 entry. I am looking for this to make next leg up next week to 3.30s. There was also positive news released about DoD funding and a potential FDA approval of a new drug early 2021 that may act as a driving catalyst for this in the medium term
Random Pick of The Week | $AKBA BioTechWelcome to the first "Random Pick of The Week", where I will randomly select a ticker to chart based on comments posted below or sent via direct message.
Want a technical breakdown?
- Follow Me
- Smash Like
- Comment 1 Ticker
Todays's Pick: AKBA / Akebia Therapeutics Inc.
Looking at the great scheme of things, we can see that AKBA has been in a steady downtrend for the last 5 years with only a few points of high demand. We've seen some massive leaps throughout the last 5 years, which is as expected knowing that we are trading biotech.
We look like we will sit in a wedge up toward the start of 2021, leaving us with sideways movement (-+8%) until. We look for a breakout and retest of this wedge if bulls have any hope of any run into the New Years'. If we break out, we have $3.95 set as a short-term target and $7 as our long-term. We must watch $2.75/$2.70 as our weekly support, if lost look to short toward $2.10/.20.
FYI: Ignore the green box, it decided to change angles last second.
DCJ | Happy Holidays
$AKBA Akebia Therapeutics, attracting Dip Buyers
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney disease. The firm also involves in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
Not so easy moneyTrendline break, HUGE upside.
Wait for the opening dump,even if it breaks the premarket peek at the open stay put waiting for that dump..then trade it from support to resistance entering above support and selling 20% below resistance.
Tight Stoploss..
Daytrading Amplitude" At least 300 shares...The daily amplitude is way below ideal for day trading...this should be treated as a ONETIME BREAK ONLY for daytrading and wait for it to settle to swing trade it...Monitor daily for entry after the big break
Good luck,
Just a tought!
AKBA doughAnalysis done on 25/05/2020
Fundamental
→ 20 & 40 SMA sloping up
→ 20MA > 40MA
Awaiting buy trigger
→ CCI <-100
→ Low of daily bar touches 20MA or goes below 20MA
→ Close above 40MA
Pull trigger
→ Buy 1 bid above previous day high
→ Sell 5 bars later exclusive of initial bar
Stop Loss
→ 50% below price bought
Akebia Therapeutics Announces Positive Top-Line Results from GloAKBA: Akebia Therapeutics
2020-05-05 06:59:00
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
AKBA: An A=C took it down to the bottom where it staged a 5-upfollowed by a 3 down to fib 76.4. Looks good for a wave 3 action.
$AKBA #AKBA second green candle confirmed Continuum of momentum with the news , expecting uptrend in directional and price appreciation for a whole next week . Target 6% here
